Altasciences has expanded its laboratory facilities in Columbia, MO. The 8,000-square-foot space includes a test material department, state-of-the-art equipment and 48 workbenches, and a vast range of services, including ligand binding assays, flow cytometry, biomarker analysis, and cell culture capabilities.

This is Altasciences’ third purpose-built lab offering scientific, regulatory, and operational expertise for quantitation of drugs and biomarkers from discovery to Phase IV, using bioanalysis platforms including mass spectrometry, ligand binding assay, PCR, flow cytometry, ELISpot, and cell based assays in routine and specialized areas such as immunomodulation and cell and gene therapy. All three labs across North America are uniformly designed and managed.

“This laboratory expansion is a significant step forward in our ability to meet the increasing needs of sponsors,” said Marie-Hélène Raigneau, co-chief operating officer, Altasciences. “Our focus on growing our bioanalytical capabilities highlights Altasciences’ mission to help develop potentially lifesaving therapeutics and get them to market faster. Our integrated CRO/CDMO services combine bioanalytical services with preclinical and clinical study solutions, manufacturing services, and all complementary research support services, for maximum efficiency.”